Vilin Bio Med Limited — Others, 10-04-2025: Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Vilin Bio Med Limited has announced a board meeting regarding the non-applicability of the Corporate Governance Report for the half-year and year ended March 31, 2025, under SEBI regulations. The company qualifies for exemptions as it has a paid-up equity share capital of less than ₹10 crore and a net worth below ₹25 crore, having listed its securities on the SME platform of NSE EMERGE. This development supports the company’s operational streamlining and compliance efficiency. Investors may view this positively, as it indicates a focus on manageable governance standards and continued compliance without burdensome requirements.